Joseph Romanelli net worth and biography

Joseph Romanelli Biography and Net Worth

Insider of Merck & Co., Inc.

Joseph Romanelli is president, Human Health International for Merck. He has P&L responsibility for Merck’s 75-plus markets outside of the U.S. and leads a team of 14,000 colleagues.

From 2021 to mid-2022, Joseph served as chief executive officer of JiXing Pharmaceuticals, a China-based biopharmaceutical company.

Prior to JiXing, Joseph served in a variety of strategic and operational roles with increasing responsibility at Merck and Schering-Plough for 25 years. He led Merck’s business in China from 2016 through 2021. During his tenure in China, Merck became the second largest multi-national pharmaceutical company by revenue in the market, as well as the second largest subsidiary for the company globally. Joseph’s previous roles at Merck include serving as chief of staff to the president of Human Health and managing the Human Health business for multiple markets in Asia Pacific. In addition, he led the Investor Relations team at Merck.

Joseph received his undergraduate degree from the University of Delaware and his master’s in Business Administration from Fordham University’s Gabelli School of Management.

What is Joseph Romanelli's net worth?: The estimated net worth of Joseph Romanelli is at least $1.72 million as of February 13th, 2024. Mr. Romanelli owns 19,569 shares of Merck & Co., Inc. stock worth more than $1,723,207 as of March 26th. This net worth evaluation does not reflect any other investments that Mr. Romanelli may own. Learn More about Joseph Romanelli's net worth.
How do I contact Joseph Romanelli?: The corporate mailing address for Mr. Romanelli and other Merck & Co., Inc. executives is 2000 GALLOPING HILL ROAD, KENILWORTH NJ, 07033. Merck & Co., Inc. can also be reached via phone at (908) 740-4000 and via email at investor_relations@merck.com. Learn More on Joseph Romanelli's contact information.
Has Joseph Romanelli been buying or selling shares of Merck & Co., Inc.?: Joseph Romanelli has not been actively trading shares of Merck & Co., Inc. during the last ninety days. Most recently, Joseph Romanelli sold 1,000 shares of the business's stock in a transaction on Tuesday, February 13th. The shares were sold at an average price of $124.89, for a transaction totalling $124,890.00. Following the completion of the sale, the insider now directly owns 19,569 shares of the company's stock, valued at $2,443,972.41. Learn More on Joseph Romanelli's trading history.
Who are Merck & Co., Inc.'s active insiders?: Merck & Co., Inc.'s insider roster includes Sanat Chattopadhyay (Insider), Frank Clyburn (EVP), Robert Davis (CFO), Richard Deluca (EVP), Cristal Downing (Insider), Kenneth Frazier (Insider), Julie Gerberding (EVP), Clark Golestani (EVP), Michael Holston (EVP), Rita Karachun (VP), Caroline Litchfield (CFO), Steven Mizell (EVP), Johannes Oosthuizen (Insider), Joseph Romanelli (Insider), Inge Thulin (Director), Ashley Watson (SVP), and Wendell Weeks (Director). Learn More on Merck & Co., Inc.'s active insiders.
Are insiders buying or selling shares of Merck & Co., Inc.?: During the last year, Merck & Co., Inc. insiders bought shares 1 times. They purchased a total of 2,833 shares worth more than $250,012.25. During the last year, insiders at the sold shares 1 times. They sold a total of 2,361 shares worth more than $209,562.36. The most recent insider tranaction occured on February, 6th when Director Inge G Thulin bought 2,833 shares worth more than $250,012.25. Insiders at Merck & Co., Inc. own 0.1% of the company. Learn More about insider trades at Merck & Co., Inc..
Information on this page was last updated on 2/6/2025.

Joseph Romanelli Insider Trading History at Merck & Co., Inc.

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
2/13/2024	Sell	1,000	$124.89	$124,890.00	19,569
4/26/2023	Buy	3	$113.68	$341.04	20,599
3/24/2023	Sell	35	$104.65	$3,662.75	20,596
3/20/2023	Buy	136	$105.47	$14,343.92	20,631
2/21/2023	Buy	11	$109.20	$1,201.20	20,495
2/15/2023	Sell	5,000	$108.22	$541,100.00	20,284

Joseph Romanelli Buying and Selling Activity at Merck & Co., Inc.

Merck & Co., Inc. Company Overview

Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock, and companion animal species. The Other segment consists of sales for the non-reportable segments of healthcare services. The company was founded in 1891 and is headquartered in Rahway, NJ.

Today's Range

Now: $88.06

$87.31

$89.32

50 Day Range

MA: $92.35

$83.01

$100.72

2 Week Range

Now: $88.06

$81.04

$134.63

Volume

13,807,591 shs

Average Volume

10,313,465 shs

Market Capitalization

$222.44 billion

P/E Ratio

13.08

Dividend Yield

3.42%

Beta

0.35